Publications
Export 65 results:
Filters: Keyword is Disease Models, Animal [Clear All Filters]
, “Mouse model of intraluminal MCAO: cerebral infarct evaluation by cresyl violet staining.”, J Vis Exp, no. 69, 2012.
, “Real-time imaging after cerebral ischemia: model systems for visualization of inflammation and neuronal repair.”, Methods Enzymol, vol. 506, pp. 117-33, 2012.
, “ALS pathogenesis: recent insights from genetics and mouse models.”, Prog Neuropsychopharmacol Biol Psychiatry, vol. 35, no. 2, pp. 363-9, 2011.
, “Animal models of human anxiety disorders: reappraisal from a developmental psychopathology vantage point.”, Pediatr Res, vol. 69, no. 5 Pt 2, p. 77R-84R, 2011.
, “Gigaxonin mutation analysis in patients with NIFID.”, Neurobiol Aging, vol. 32, no. 8, pp. 1528-9, 2011.
, “Model system for live imaging of neuronal responses to injury and repair.”, Mol Imaging, vol. 10, no. 6, pp. 434-45, 2011.
, “Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.”, Brain, vol. 134, no. Pt 9, pp. 2610-26, 2011.
, “Distinct biochemical signatures characterize peripherin isoform expression in both traumatic neuronal injury and motor neuron disease.”, J Neurochem, vol. 114, no. 4, pp. 1177-92, 2010.
, “Induction of protective immunity by vaccination with wild-type apo superoxide dismutase 1 in mutant SOD1 transgenic mice.”, J Neuropathol Exp Neurol, vol. 69, no. 10, pp. 1044-56, 2010.
, “Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia.”, Ann Neurol, vol. 68, no. 5, pp. 619-28, 2010.
, “Neuronal over-expression of chromogranin A accelerates disease onset in a mouse model of ALS.”, J Neurochem, vol. 115, no. 5, pp. 1102-11, 2010.
, “Reversal of neuropathy phenotypes in conditional mouse model of Charcot-Marie-Tooth disease type 2E.”, Hum Mol Genet, vol. 19, no. 13, pp. 2616-29, 2010.
, “Wild-type human SOD1 overexpression does not accelerate motor neuron disease in mice expressing murine Sod1 G86R.”, Neurobiol Dis, vol. 40, no. 1, pp. 245-50, 2010.
, “Inflammation, plasticity and real-time imaging after cerebral ischemia.”, Acta Neuropathol, vol. 117, no. 5, pp. 497-509, 2009.
, “Live imaging of amyotrophic lateral sclerosis pathogenesis: disease onset is characterized by marked induction of GFAP in Schwann cells.”, Glia, vol. 57, no. 10, pp. 1130-42, 2009.
, “Real-time in vivo assessment of the nerve microenvironment with coherent anti-Stokes Raman scattering microscopy.”, Plast Reconstr Surg, vol. 123, no. 2 Suppl, p. 123S-30S, 2009.
, “Als2 mRNA splicing variants detected in KO mice rescue severe motor dysfunction phenotype in Als2 knock-down zebrafish.”, Hum Mol Genet, vol. 17, no. 17, pp. 2691-702, 2008.
, “EPSP depression following neocortical seizures in cat.”, Epilepsia, vol. 49, no. 4, pp. 705-9, 2008.
, “Gene-environment interaction and behavioral disorders: a developmental perspective based on endophenotypes.”, Novartis Found Symp, vol. 293, pp. 31-41; discussion 41-7, 68-70, 2008.
, “L-Dopa treatment abolishes the numerical increase in striatal dopaminergic neurons in parkinsonian monkeys.”, J Chem Neuroanat, vol. 35, no. 1, pp. 77-84, 2008.
, “Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1.”, J Neurochem, vol. 107, no. 1, pp. 253-64, 2008.
, “Requirement of myeloid cells for axon regeneration.”, J Neurosci, vol. 28, no. 38, pp. 9363-76, 2008.
, “Synaptic strength modulation after cortical trauma: a role in epileptogenesis.”, J Neurosci, vol. 28, no. 27, pp. 6760-72, 2008.
, “ALS: astrocytes move in as deadly neighbors.”, Nat Neurosci, vol. 10, no. 5, pp. 535-7, 2007.
, “Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis.”, Proc Natl Acad Sci U S A, vol. 104, no. 7, pp. 2495-500, 2007.
